antitubercular agents

Preferred Label : antitubercular agents;

MeSH definition : Drugs used in the treatment of tuberculosis. They are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.;

MeSH synonym : antitubercular drugs; tuberculostatic agents; Anti-Tuberculosis Agent; Agent, Anti-Tuberculosis; Anti Tuberculosis Agent; Anti-Tuberculosis Drug; Anti Tuberculosis Drug; Drug, Anti-Tuberculosis; Tuberculostatic Agent; Agent, Tuberculostatic; Anti-Tuberculosis Drugs; Anti Tuberculosis Drugs; Anti-Tuberculosis Agents; Anti Tuberculosis Agents; Antitubercular Agent; Agent, Antitubercular; Antitubercular Drug; Drug, Antitubercular;

CISMeF synonym : agents, antitubercular; agents, tuberculostatic; drugs, antitubercular;

MeSH annotation : consider also MYCOBACTERIUM TUBERCULOSIS /drug eff & TUBERCULOSIS /drug ther;

Wikipedia link : https://en.wikipedia.org/wiki/Antitubercular agents;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000995;

UMLS CUI

C0003448;

ATC code(s)
- aminosalicylic acid [ATC Code]
- aminosalicylic acid and derivatives [ATC Code]
- calcium aminosalicylate [ATC Code]
- combinations of drugs for treatment of tuberculosis [ATC Code]
- drugs for treatment of tuberculosis [ATC Code]
- ethionamide [ATC Code]
- hydrazides [ATC Code]
- other drugs for treatment of tuberculosis [ATC Code]
- protionamide [ATC Code]
- sodium aminosalicylate [ATC Code]
- terizidone [ATC Code]
- tiocarlide [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Antituberculars [ICHI extension code]
- other drugs for treatment of tuberculosis [ATC Code]
CISMeF manual mappings
- Antituberculars [ICD-11 Extension code]
- Antituberculous drug adverse reaction (disorder) [SNOMED CT concept]
Indexing information
- 1-(2',3',4',6'-tetra-O-acetylglucopyranosyl)-4-(3-hydroxyphenyl)but-3-en-2-one [MeSH Supplementary Concept]
- 1-(3-(3-propoxyphenylcarbamoyloxy)-2-hydroxypropyl)-4-(3-trifluoromethylphenyl)piperazinium chloride [MeSH Supplementary Concept]
- 13-hydroxy-5(10),14-halimadien-6-one [MeSH Supplementary Concept]
- 2-(2-methyl-1,4-dioxa-8-azaspiro(4.5)dec-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one [MeSH Supplementary Concept]
- 2-(3-bromophenylamino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium [MeSH Supplementary Concept]
- 2-(4-chloroanilino)-5-cyclopropyl-3-(4-methoxycyclohexyl)imino-3,5-dihydrophenazine [MeSH Supplementary Concept]
- 2-(4-methoxy-2-methylphenyl)-3H-benzofuro(3,2-e)benzofuran [MeSH Supplementary Concept]
- 4,6-dichloro-N-(4,4-dimethylcyclohexyl)-1H-indole-2-carboxamide [MeSH Supplementary Concept]
- 4-benzoyl-2-nitrophenyl thiocyanate [MeSH Supplementary Concept]
- 5-((2-(4-hydroxyphenyl)ethoxy)methyl)-1H-pyrrole-2-carbaldehyde [MeSH Supplementary Concept]
- 5-(2-hydroxyethyl)-2-methyl-2-tetradecylfuran-3(2H)-one [MeSH Supplementary Concept]
- 6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-2-(3-(trifluoromethylthio)phenylamino)-3,6-dihydropyrimidin-1-ium [MeSH Supplementary Concept]
- 6alpha,7alpha-diacetoxy-13-hydroxy-8(9),14-labdadien [MeSH Supplementary Concept]
- 7-methylpicene-1,2-diol [MeSH Supplementary Concept]
- 8-hydroxyquinolinecarboxylic acid [MeSH Supplementary Concept]
- 9-hydroxy-13(14)-labden-15,16-olide [MeSH Supplementary Concept]
- CPZEN-45 [MeSH Supplementary Concept]
- S 14001 [MeSH Supplementary Concept]
- SRI 224 [MeSH Supplementary Concept]
- TCA1 compound [MeSH Supplementary Concept]
- abyssomicin J [MeSH Supplementary Concept]
- abyssomicin K [MeSH Supplementary Concept]
- abyssomicin L [MeSH Supplementary Concept]
- bedaquiline [MeSH Supplementary Concept]
- brevianamide S [MeSH Supplementary Concept]
- epidiselenodiketopiperazine [MeSH Supplementary Concept]
- erogorgiane [MeSH Supplementary Concept]
- eupomatenoid-3 [MeSH Supplementary Concept]
- hytramycin I [MeSH Supplementary Concept]
- hytramycin V [MeSH Supplementary Concept]
- leubethanol [MeSH Supplementary Concept]
- lichexanthone [MeSH Supplementary Concept]
- pretomanid [MeSH Supplementary Concept]
- texaline [MeSH Supplementary Concept]
Record concept(s)
- antitubercular agents [MeSH concept]
See also
- mycobacterium tuberculosis [MeSH Descriptor]
- tuberculosis [MeSH Descriptor]
- tuberculosis, multidrug-resistant [MeSH Descriptor]
See also inter- (CISMeF)
- Medicinal product acting as antitubercular agent (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- aconiazide [MeSH Supplementary Concept]
- aminosalicylic acid [MeSH Descriptor]
- atratumycin [MeSH Supplementary Concept]
- bedaquiline [MeSH Supplementary Concept]
- dextrazide [MeSH Supplementary Concept]
- diarylquinolines [MeSH Descriptor]
- ecumicin [MeSH Supplementary Concept]
- essential 303 forte [MeSH Supplementary Concept]
- ethambutol [MeSH Descriptor]
- ethionamide [MeSH Descriptor]
- isoniazid [MeSH Descriptor]
- isoniazid, pyrazinamide, rifampin drug combination [MeSH Supplementary Concept]
- macozinone [MeSH Supplementary Concept]
- ohmyungsamycin A [MeSH Supplementary Concept]
- pazufloxacin [MeSH Supplementary Concept]
- perchlozone [MeSH Supplementary Concept]
- prothionamide [MeSH Descriptor]
- pyrazinamide [MeSH Descriptor]
- sodium thiosulfate [MeSH Supplementary Concept]
- sparfloxacin [MeSH Supplementary Concept]
- thioacetazone [MeSH Descriptor]
- thiobenzamide [MeSH Supplementary Concept]
- thiocarlide [MeSH Supplementary Concept]
- thymopoietin III [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients